HCM Stock Summary and Trading Ideas (Hutchmed (China) Limited - American Depositary Shares | NASDAQ:HCM)

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Hutchmed (China) Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol HCM.

As of April 22, 2026, HCM stock price declined to $14.56 with 15,552 million shares trading.

HCM has a beta of 0.80, meaning it tends to be less sensitive to market movements. HCM has a correlation of 0.07 to the broad based SPY ETF.

HCM has a market cap of $2.50 billion. This is considered a Mid Cap stock.

Last quarter Hutchmed (China) Limited - American Depositary Shares reported $549 million in Revenue and $2.62 earnings per share. This fell short of revenue expectation by $-43 million and exceeded earnings estimates by $1.19.

In the last 3 years, HCM traded as high as $21.92 and as low as $10.68.

The top ETF exchange traded funds that HCM belongs to (by Net Assets): SPDW, CANC, DFEM, NSI, DFAX.

HCM has underperformed the market in the last year with a price return of +4.8% while the SPY ETF gained +39.8%. HCM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.1% and -5.4%, respectively, while the SPY returned +4.0% and +7.9%, respectively.

HCM support price is $14.45 and resistance is $15.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCM shares will trade within this expected range on the day.